An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.

Citation data:

Gynecologic oncology, ISSN: 1095-6859, Vol: 147, Issue: 2, Page: 243-249

Publication Year:
2017
Usage 21
Clicks 10
Abstract Views 9
Link-outs 2
Citations 3
Citation Indexes 3
PMID:
28807367
DOI:
10.1016/j.ygyno.2017.08.004
Author(s):
Oliver, Kate E; Brady, William E; Birrer, Michael; Gershenson, David M; Fleming, Gini; Copeland, Larry J; Tewari, Krishnansu; Argenta, Peter A; Mannel, Robert S; Secord, Angeles Alvarez; Stephan, Jean-Marie; Mutch, David G; Stehman, Frederick B; Muggia, Franco M; Rose, Peter G; Armstrong, Deborah K; Bookman, Michael A; Burger, Robert A; Farley, John H Show More Hide
Publisher(s):
Elsevier BV
Tags:
Medicine
article description
We examined disparities in prognosis between patients with ovarian clear cell carcinoma (OCCC) and serous epithelial ovarian cancer (SOC).